P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy. (12th March 2014)

Record Type:: Journal Article
Title:: P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy. (12th March 2014)
Main Title:: P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy
Authors:: Weiler, K
Rava, L
Jäger, M
Funke, I
Joka, M
Jauch, KW
Mayer, B
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 2(2014)Supplement 2
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 2(2014)Supplement 2
Issue Display:: Volume 2, Issue 2 (2014)
Year:: 2014
Volume:: 2
Issue:: 2
Issue Sort Value:: 2014-0002-0002-0000
Page Start:
Page End:
Publication Date:: 2014-03-12
Subjects:: Tumour Spheroid -- EpCAM Expression -- Ficoll Density Gradient -- Significant Therapeutic Effect -- Autologous PBMCs
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-2-S2-P9 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19198.xml